Status

PDF |Add To My Favorites |Track Bill | print page

AB-2122 Medi-Cal: blood lead screening tests.(2017-2018)

Senate:1stCmt2ndCmt2nd3rdPass
Assembly:1stCmt2ndCmt2nd3rdPassPassVeto
Bill Status
AB-2122
Reyes (A)
Arambula (A) , Leyva (S)
Cristina Garcia (A) , Hueso (S) , Santiago (A)
Medi-Cal: blood lead screening tests.
03/11/18
An act to add Section 105287 to the Health and Safety Code, and to amend Section 14197.05 of, and to add Sections 14087.42 and 14132.015 to, the Welfare and Institutions Code, relating to Medi-Cal.
Assembly
09/04/18
08/17/18

Type of Measure
Inactive Bill - Vetoed
Majority Vote Required
Non-Appropriation
Fiscal Committee
Non-State-Mandated Local Program
Non-Urgency
Non-Tax levy
Last 5 History Actions
Date Action
09/22/18 Vetoed by Governor.
09/10/18 Enrolled and presented to the Governor at 3:30 p.m.
08/30/18 Senate amendments concurred in. To Engrossing and Enrolling. (Ayes 80. Noes 0. Page 6976.).
08/23/18 In Assembly. Concurrence in Senate amendments pending. May be considered on or after August 25 pursuant to Assembly Rule 77.
08/23/18 Read third time. Passed. Ordered to the Assembly. (Ayes 39. Noes 0. Page 5655.).
Governor's Veto Message
To the Members of the California State Assembly:

I am returning Assembly Bill 2122 without my signature.

This bill would set statewide goals for blood lead level screening tests for children in Medi-Cal and require the Department of Health Care Services to ensure these goals are met.

Lead exposure in children is a serious health concern and I share the author's desire to increase the number of Medi-Cal children who are screened. The department, however, already requires in its contracts with managed care plans and providers that children receive screenings in accordance with federal and state regulations. Updated and more thorough data on periodic screening tests is being developed with the Department of Public Health to assist in tracking compliance.

I believe the department should continue its current efforts working with managed care plans, health care providers and public health officials to determine what additional policies and practices may be necessary to improve screening rates.

Sincerely,



Edmund G. Brown Jr.